BE852941A - Nouveaux derives de prostaglandine - Google Patents
Nouveaux derives de prostaglandineInfo
- Publication number
- BE852941A BE852941A BE176164A BE176164A BE852941A BE 852941 A BE852941 A BE 852941A BE 176164 A BE176164 A BE 176164A BE 176164 A BE176164 A BE 176164A BE 852941 A BE852941 A BE 852941A
- Authority
- BE
- Belgium
- Prior art keywords
- prostaglandin derivatives
- new prostaglandin
- new
- derivatives
- prostaglandin
- Prior art date
Links
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL49325A IL49325A (en) | 1976-03-31 | 1976-03-31 | 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
BE852941A true BE852941A (fr) | 1977-09-28 |
Family
ID=11048789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE176164A BE852941A (fr) | 1976-03-31 | 1977-03-28 | Nouveaux derives de prostaglandine |
Country Status (18)
Country | Link |
---|---|
US (1) | US4115401A (no) |
JP (1) | JPS52142060A (no) |
BE (1) | BE852941A (no) |
CA (1) | CA1074804A (no) |
CH (2) | CH624101A5 (no) |
DD (1) | DD130352A5 (no) |
DE (1) | DE2714129A1 (no) |
ES (1) | ES457385A1 (no) |
FR (1) | FR2346332A1 (no) |
GB (1) | GB1574246A (no) |
HU (1) | HU178040B (no) |
IL (1) | IL49325A (no) |
IT (1) | IT1075373B (no) |
NL (1) | NL7703503A (no) |
NO (1) | NO149428C (no) |
PL (3) | PL108289B1 (no) |
SE (1) | SE417603B (no) |
SU (3) | SU676162A3 (no) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003074483A1 (fr) | 2002-03-05 | 2003-09-12 | Ono Pharmaceutical Co., Ltd. | Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5536475A (en) * | 1978-07-11 | 1980-03-14 | Glaxo Group Ltd | Prostanoid compound |
US4320136A (en) * | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
US4456613A (en) * | 1982-12-27 | 1984-06-26 | E. I. Du Pont De Nemours And Company | 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof |
US4530933A (en) * | 1982-12-27 | 1985-07-23 | E. I. Du Pont De Nemours And Company | 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents |
OA12117A (en) | 1999-12-22 | 2006-05-04 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis. |
PT1339678E (pt) * | 2000-11-27 | 2007-11-30 | Pfizer Prod Inc | Agonistas selectivos do receptor ep4 no tratamento de osteoporose |
AU2002328338C1 (en) * | 2001-07-16 | 2009-01-08 | Ono Pharmaceutical Co., Ltd | 2 pyrrolidone derivatives as prostanoid agonists |
BR0211201A (pt) | 2001-07-16 | 2004-07-13 | Hoffmann La Roche | Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero |
TWI313608B (en) | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
CA2479222A1 (en) * | 2002-03-18 | 2003-09-25 | Pfizer Products Inc. | Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension |
MXPA05007341A (es) * | 2003-01-10 | 2005-09-30 | Hoffmann La Roche | Derivados de 2-piperidona como agonistas de prostaglandina. |
US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
US20080058375A1 (en) * | 2004-01-08 | 2008-03-06 | Elworthy Todd R | 2-Piperidone derivatives as prostaglandin antagonists |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3975399A (en) * | 1974-08-06 | 1976-08-17 | E. I. Du Pont De Nemours And Company | 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones |
-
1976
- 1976-03-31 IL IL49325A patent/IL49325A/xx unknown
-
1977
- 1977-03-28 BE BE176164A patent/BE852941A/xx not_active IP Right Cessation
- 1977-03-28 GB GB12991/77A patent/GB1574246A/en not_active Expired
- 1977-03-29 DD DD7700198124A patent/DD130352A5/xx unknown
- 1977-03-29 PL PL1977210102A patent/PL108289B1/pl unknown
- 1977-03-29 PL PL1977197005A patent/PL107643B1/pl unknown
- 1977-03-29 PL PL1977210101A patent/PL107544B1/pl unknown
- 1977-03-30 HU HU77LA913A patent/HU178040B/hu unknown
- 1977-03-30 SE SE7703698A patent/SE417603B/xx unknown
- 1977-03-30 NO NO771134A patent/NO149428C/no unknown
- 1977-03-30 CH CH400377A patent/CH624101A5/fr not_active IP Right Cessation
- 1977-03-30 DE DE19772714129 patent/DE2714129A1/de not_active Withdrawn
- 1977-03-30 CA CA275,134A patent/CA1074804A/en not_active Expired
- 1977-03-31 JP JP3742877A patent/JPS52142060A/ja active Pending
- 1977-03-31 US US05/783,284 patent/US4115401A/en not_active Expired - Lifetime
- 1977-03-31 ES ES457385A patent/ES457385A1/es not_active Expired
- 1977-03-31 FR FR7709650A patent/FR2346332A1/fr active Granted
- 1977-03-31 NL NL7703503A patent/NL7703503A/xx not_active Application Discontinuation
- 1977-03-31 SU SU772465855A patent/SU676162A3/ru active
- 1977-03-31 IT IT21906/77A patent/IT1075373B/it active
-
1978
- 1978-03-30 SU SU782594353A patent/SU837321A3/ru active
- 1978-03-30 SU SU782595450A patent/SU715019A3/ru active
-
1980
- 1980-09-17 CH CH697780A patent/CH628032A5/fr not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003074483A1 (fr) | 2002-03-05 | 2003-09-12 | Ono Pharmaceutical Co., Ltd. | Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif |
Also Published As
Publication number | Publication date |
---|---|
JPS52142060A (en) | 1977-11-26 |
SE7703698L (sv) | 1977-10-01 |
SU676162A3 (ru) | 1979-07-25 |
IT1075373B (it) | 1985-04-22 |
CA1074804A (en) | 1980-04-01 |
PL107643B1 (pl) | 1980-02-29 |
DE2714129A1 (de) | 1977-10-13 |
US4115401A (en) | 1978-09-19 |
NO149428C (no) | 1984-04-18 |
NL7703503A (nl) | 1977-10-04 |
CH628032A5 (fr) | 1982-02-15 |
PL197005A1 (pl) | 1978-10-09 |
NO771134L (no) | 1977-10-03 |
FR2346332B1 (no) | 1980-05-09 |
PL108289B1 (pl) | 1980-03-31 |
IL49325A (en) | 1979-11-30 |
ES457385A1 (es) | 1978-02-01 |
HU178040B (en) | 1982-02-28 |
SU715019A3 (ru) | 1980-02-05 |
PL107544B1 (pl) | 1980-02-29 |
CH624101A5 (no) | 1981-07-15 |
FR2346332A1 (fr) | 1977-10-28 |
IL49325A0 (en) | 1976-05-31 |
SE417603B (sv) | 1981-03-30 |
DD130352A5 (de) | 1978-03-22 |
GB1574246A (en) | 1980-09-03 |
NO149428B (no) | 1984-01-09 |
SU837321A3 (ru) | 1981-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE851122A (fr) | Nouveaux derives de prostaglandine | |
BE852060A (fr) | Derives polyoxygenes du labdane | |
BE859912A (fr) | Nouveaux derives de psoralene | |
BE860741A (fr) | Derives du glucofurannose | |
NL7714172A (nl) | Prostaglandinederivaten. | |
BE852941A (fr) | Nouveaux derives de prostaglandine | |
BE852141A (fr) | Nouveaux derives de sulfonamide | |
BE851846A (fr) | Derives de 1-nitro-9-amonoacridine | |
BE850492A (fr) | Nouveaux derives de la piperazine | |
MC1143A1 (fr) | Derives de thiouree | |
NL7607800A (nl) | Prostaglandinederivaten. | |
BE851443A (fr) | Nouveaux derives de la piperazine | |
BE859567A (fr) | Derives piperidylideniques de benzo-xanthenes | |
BE852457A (fr) | Nouveaux derives 17-spirosultines | |
BE852813A (fr) | Derives de la nicotinoylaminotriazine | |
NL7807292A (nl) | Prostaglandinederivaten. | |
FR2322587A1 (fr) | Derives du prostane | |
FR2351084A1 (fr) | Nouveaux derives naphtyliques | |
FR2341570A1 (fr) | Derives de la piperidine | |
BE857719A (fr) | Derives de prostane | |
FR2313920A1 (fr) | Derives du prostane | |
BE855851A (fr) | Nouveaux derives de la nitroxoline | |
BE851503A (fr) | Nouveaux derives de la 2-phenyl-2-hydroxyethylamine | |
MC1133A1 (fr) | Derives de dibenzothyphene | |
FR2353291A1 (fr) | Nouveaux derives du benzofuranne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: SANOFI Effective date: 19850328 |